Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | NFXL1 | Human | (+)-schisandrin B | multiple interactions | ISO | Nfxl1 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NFXL1 mRNA] | CTD | PMID:31150632 | NFXL1 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Nfxl1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of NFXL1 mRNA | CTD | PMID:36331819 | NFXL1 | Human | 1,2-dichloroethane | decreases expression | ISO | Nfxl1 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of NFXL1 mRNA | CTD | PMID:28960355 | NFXL1 | Human | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of NFXL1 mRNA | CTD | PMID:20106945 and PMID:31614463 | NFXL1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Nfxl1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NFXL1 mRNA | CTD | PMID:19465110 and PMID:21354282 | NFXL1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Nfxl1 (Mus musculus) | 6480464 | [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of NFXL1 mRNA | CTD | PMID:25975270 | NFXL1 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of NFXL1 gene | CTD | PMID:27153756 | NFXL1 | Human | amitrole | decreases expression | ISO | Nfxl1 (Rattus norvegicus) | 6480464 | Amitrole results in decreased expression of NFXL1 mRNA | CTD | PMID:38685447 | NFXL1 | Human | atazanavir sulfate | multiple interactions | EXP | | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of NFXL1 mRNA | CTD | PMID:33819548 | NFXL1 | Human | bisphenol A | affects methylation | ISO | Nfxl1 (Mus musculus) | 6480464 | bisphenol A affects the methylation of NFXL1 promoter | CTD | PMID:27334623 | NFXL1 | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of NFXL1 protein | CTD | PMID:33376534 | NFXL1 | Human | bisphenol A | increases methylation | ISO | Nfxl1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of NFXL1 gene | CTD | PMID:28505145 | NFXL1 | Human | butanal | increases methylation | EXP | | 6480464 | butyraldehyde results in increased methylation of NFXL1 gene | CTD | PMID:30002397 | NFXL1 | Human | carbamazepine | affects expression | EXP | | 6480464 | Carbamazepine affects the expression of NFXL1 mRNA | CTD | PMID:25979313 | NFXL1 | Human | carbon nanotube | increases expression | ISO | Nfxl1 (Mus musculus) | 6480464 | Nanotubes and Carbon results in increased expression of NFXL1 mRNA | CTD | PMID:25620056 | NFXL1 | Human | chenodeoxycholic acid | multiple interactions | EXP | | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of NFXL1 mRNA more ... | CTD | PMID:33819548 | NFXL1 | Human | chlorpyrifos | decreases expression | ISO | Nfxl1 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of NFXL1 mRNA | CTD | PMID:37019170 | NFXL1 | Human | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of NFXL1 mRNA | CTD | PMID:27392435 | NFXL1 | Human | coumarin | decreases phosphorylation | EXP | | 6480464 | coumarin results in decreased phosphorylation of NFXL1 protein | CTD | PMID:35688186 | NFXL1 | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of NFXL1 mRNA | CTD | PMID:20106945 more ... | NFXL1 | Human | cyclosporin A | multiple interactions | EXP | | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in increased expression of NFXL1 mRNA | CTD | PMID:33819548 | NFXL1 | Human | cyclosporin A | decreases methylation | EXP | | 6480464 | Cyclosporine results in decreased methylation of NFXL1 promoter | CTD | PMID:27989131 | NFXL1 | Human | deoxycholic acid | multiple interactions | EXP | | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of NFXL1 mRNA more ... | CTD | PMID:33819548 | NFXL1 | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of NFXL1 mRNA | CTD | PMID:37042841 | NFXL1 | Human | formaldehyde | decreases expression | EXP | | 6480464 | Formaldehyde results in decreased expression of NFXL1 mRNA | CTD | PMID:20655997 | NFXL1 | Human | FR900359 | increases phosphorylation | EXP | | 6480464 | FR900359 results in increased phosphorylation of NFXL1 protein | CTD | PMID:37730182 | NFXL1 | Human | gallic acid | decreases expression | EXP | | 6480464 | Gallic Acid results in decreased expression of NFXL1 mRNA | CTD | PMID:34408198 | NFXL1 | Human | glycochenodeoxycholic acid | multiple interactions | EXP | | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of NFXL1 mRNA more ... | CTD | PMID:33819548 | NFXL1 | Human | glycocholic acid | multiple interactions | EXP | | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of NFXL1 mRNA more ... | CTD | PMID:33819548 | NFXL1 | Human | glycodeoxycholic acid | multiple interactions | EXP | | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of NFXL1 mRNA more ... | CTD | PMID:33819548 | NFXL1 | Human | heptanal | increases methylation | EXP | | 6480464 | heptanal results in increased methylation of NFXL1 gene | CTD | PMID:30002397 | NFXL1 | Human | hexanal | increases methylation | EXP | | 6480464 | n-hexanal results in increased methylation of NFXL1 gene | CTD | PMID:30002397 | NFXL1 | Human | methimazole | decreases expression | ISO | Nfxl1 (Rattus norvegicus) | 6480464 | Methimazole results in decreased expression of NFXL1 mRNA | CTD | PMID:38685447 | NFXL1 | Human | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of NFXL1 mRNA | CTD | PMID:23649840 | NFXL1 | Human | N-methyl-4-phenylpyridinium | increases expression | ISO | Nfxl1 (Rattus norvegicus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of NFXL1 mRNA | CTD | PMID:28801915 | NFXL1 | Human | nefazodone | multiple interactions | EXP | | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of NFXL1 mRNA | CTD | PMID:33819548 | NFXL1 | Human | nonanal | increases methylation | EXP | | 6480464 | nonanal results in increased methylation of NFXL1 gene | CTD | PMID:30002397 | NFXL1 | Human | octanal | increases methylation | EXP | | 6480464 | caprylic aldehyde results in increased methylation of NFXL1 gene | CTD | PMID:30002397 | NFXL1 | Human | paracetamol | affects expression | ISO | Nfxl1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of NFXL1 mRNA | CTD | PMID:17562736 | NFXL1 | Human | pentanal | increases methylation | EXP | | 6480464 | pentanal results in increased methylation of NFXL1 gene | CTD | PMID:30002397 | NFXL1 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Nfxl1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of NFXL1 mRNA | CTD | PMID:36331819 | NFXL1 | Human | perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of NFXL1 protein | CTD | PMID:26879310 | NFXL1 | Human | phenobarbital | affects expression | ISO | Nfxl1 (Mus musculus) | 6480464 | Phenobarbital affects the expression of NFXL1 mRNA | CTD | PMID:23091169 | NFXL1 | Human | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of NFXL1 mRNA | CTD | PMID:19710929 | NFXL1 | Human | pirinixic acid | multiple interactions | ISO | Nfxl1 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of NFXL1 mRNA | CTD | PMID:19710929 | NFXL1 | Human | pregnenolone 16alpha-carbonitrile | decreases expression | ISO | Nfxl1 (Mus musculus) | 6480464 | Pregnenolone Carbonitrile results in decreased expression of NFXL1 mRNA | CTD | PMID:28903501 | NFXL1 | Human | progesterone | increases expression | EXP | | 6480464 | Progesterone results in increased expression of NFXL1 mRNA | CTD | PMID:21795739 | NFXL1 | Human | propanal | increases methylation | EXP | | 6480464 | propionaldehyde results in increased methylation of NFXL1 gene | CTD | PMID:30002397 | NFXL1 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of NFXL1 mRNA | CTD | PMID:23557933 | NFXL1 | Human | silicon dioxide | increases expression | ISO | Nfxl1 (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of NFXL1 mRNA | CTD | PMID:23221170 | NFXL1 | Human | silver atom | decreases expression | ISO | Nfxl1 (Mus musculus) | 6480464 | Silver results in decreased expression of NFXL1 mRNA | CTD | PMID:27131904 | NFXL1 | Human | silver(0) | decreases expression | ISO | Nfxl1 (Mus musculus) | 6480464 | Silver results in decreased expression of NFXL1 mRNA | CTD | PMID:27131904 | NFXL1 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of NFXL1 mRNA | CTD | PMID:38568856 | NFXL1 | Human | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of NFXL1 mRNA | CTD | PMID:31533062 | NFXL1 | Human | tetrachloromethane | multiple interactions | ISO | Nfxl1 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of NFXL1 mRNA] | CTD | PMID:31150632 | NFXL1 | Human | tetrachloromethane | increases expression | ISO | Nfxl1 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of NFXL1 mRNA | CTD | PMID:31919559 | NFXL1 | Human | tetrachloromethane | increases expression | ISO | Nfxl1 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in increased expression of NFXL1 mRNA | CTD | PMID:31150632 | NFXL1 | Human | thiram | increases expression | EXP | | 6480464 | Thiram results in increased expression of NFXL1 mRNA | CTD | PMID:38568856 | NFXL1 | Human | titanium dioxide | increases methylation | EXP | | 6480464 | titanium dioxide results in increased methylation of NFXL1 gene | CTD | PMID:34973136 | NFXL1 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of NFXL1 mRNA | CTD | PMID:37042841 | NFXL1 | Human | triptonide | affects expression | ISO | Nfxl1 (Mus musculus) | 6480464 | triptonide affects the expression of NFXL1 mRNA | CTD | PMID:33045310 | NFXL1 | Human | triticonazole | decreases expression | ISO | Nfxl1 (Rattus norvegicus) | 6480464 | triticonazole results in decreased expression of NFXL1 mRNA | CTD | PMID:36084822 | NFXL1 | Human | tunicamycin | increases expression | ISO | Nfxl1 (Mus musculus) | 6480464 | Tunicamycin results in increased expression of NFXL1 mRNA | CTD | PMID:17127020 | NFXL1 | Human | tunicamycin | increases expression | EXP | | 6480464 | Tunicamycin results in increased expression of NFXL1 mRNA | CTD | PMID:22378314 and PMID:29453283 | NFXL1 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of NFXL1 mRNA | CTD | PMID:29154799 | NFXL1 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of NFXL1 mRNA | CTD | PMID:23179753 | NFXL1 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of NFXL1 mRNA | CTD | PMID:25979313 | NFXL1 | Human | vinclozolin | affects expression | ISO | Nfxl1 (Rattus norvegicus) | 6480464 | vinclozolin affects the expression of NFXL1 mRNA | CTD | PMID:23034163 | |